Buchumschlag

Impact of Transmission Dynamics and Treatment Uptake, Frequency and Timing on the Cost-effectiveness of Directly Acting Antivirals for Hepatitis C Virus Infection

Fuente: arXiv

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Das, Soham, Sood, Ajit, Midha, Vandana, Singh, Arshdeep, Sharma, Pranjl, Ramamohan, Varun
Format:	Preprint
Veröffentlicht:	2024
Schlagworte:	Systems and Control
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024
von: Chieu‐Hoang Ly Luong, et al.
Veröffentlicht: (2025)

Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis
von: Arshdeep Singh, et al.
Veröffentlicht: (2025)

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
von: Javeria Khalid, et al.
Veröffentlicht: (2026)

The Dietary Journey in Inflammatory Bowel Disease: A Grounded Theory From Medicalization to Empowerment
von: Rubina Khullar Mahajan, et al.
Veröffentlicht: (2026)

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
von: Yu‐Ping Chang, et al.
Veröffentlicht: (2025)

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
von: Nobuharu Tamaki, et al.
Veröffentlicht: (2025)

Impact of Direct‐Acting Antiviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus Nucleic Acid Testing‐Positive Transplant Recipients
von: Jared Walz, et al.
Veröffentlicht: (2025)

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection—Authors' Reply
von: Yu‐Ping Chang, et al.
Veröffentlicht: (2025)

Impact of Direct‐Acting Antiviral Therapy on All‐Cause Mortality in Chronic Hepatitis C Patients
von: Wei‐Zhen Tang, et al.
Veröffentlicht: (2024)

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort
von: Brendan L. Harney, et al.
Veröffentlicht: (2024)

Clearance of Hepatitis C Viremia During Direct‐Acting Antiviral Therapy Leads to Rapid Changes in Lipid and Lipoprotein Metabolism
von: Zahra Sarrafan‐Chaharsoughi, et al.
Veröffentlicht: (2025)

Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy
von: Ying‐Nan Tsai, et al.
Veröffentlicht: (2024)

Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy
von: Francesco Saverio Mennini, et al.
Veröffentlicht: (2025)

Direct‐Acting Antiviral Treatment Failure and Retreatment Strategies Following Hepatitis C‐Positive Solid Organ Transplantation in Hepatitis C‐Negative Recipients: A Multicenter Case Series
von: Alicia B. Carver, et al.
Veröffentlicht: (2025)

Prediction of Hepatocellular Carcinoma After Direct‐Acting Antiviral Therapy Using Agile 3+ and End‐of‐Treatment Alpha‐Fetoprotein Levels in Patients With Hepatitis C
von: Akifumi Kuwano, et al.
Veröffentlicht: (2025)

Modeling of Hepatitis B Virus Transmission With Vaccination, Treatment, and Memory Effects
von: Taruna Garg, et al.
Veröffentlicht: (2025)

Cytoskeletal Vimentin Directs Cell‐Cell Transmission of Hepatitis C Virus
von: Yifan Xing, et al.
Veröffentlicht: (2024)

A Case Report of Direct‐Acting Antiviral Therapy for Chronic Hepatitis C in a Patient With Dementia Treated in Collaboration With Multiple Specialists
von: Tomoki Tanie, et al.
Veröffentlicht: (2026)

Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis
von: Haris Imsirovic, et al.
Veröffentlicht: (2024)

Healthcare Facility Assignment Using Real-Time Length-of-Stay Predictions: Queuing-Theoretic and Simulation-driven Machine Learning Approaches
von: Fatma, Najiya, et al.
Veröffentlicht: (2026)

Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan
von: Hironori Ochi, et al.
Veröffentlicht: (2026)

Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin
von: Mohamed Abdel‐Samiee, et al.
Veröffentlicht: (2025)

Clinico‐Pathological Spectrum of Hepatitis A Virus‐Induced Autoimmune‐Like Hepatitis in Children
von: Samannay Das, et al.
Veröffentlicht: (2024)

Scalable Substructure Discovery Algorithm For Homogeneous Multilayer Networks
von: Singh, Arshdeep, et al.
Veröffentlicht: (2025)

Comment on “Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan”
von: Haonan Jin
Veröffentlicht: (2026)

Letter to the Editor: “Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan”
von: Haigu Ke, et al.
Veröffentlicht: (2026)

Unrecognized Transmission Risks of Occult Hepatitis B Virus Infection Among Blood Donors in Central Ethiopia
von: Gizachew Beykaso, et al.
Veröffentlicht: (2026)

Co‐Administration of Hepatitis C Direct‐Acting Antivirals and Enzyme‐Inducing Antiepileptic Drugs: Real‐World Experience From a Multi‐Centre Case Series
von: R. Harrison, et al.
Veröffentlicht: (2026)

Different Sequential Renal Involvement in a Patient With HIV and Hepatitis C: From HIV‐ or Leishmaniasis‐Related Collapsing Glomerulosclerosis to Direct‐Acting Antivirals’ Renal Amyloidosis
von: María Adoración Martín Gómez, et al.
Veröffentlicht: (2026)

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm
von: Gian Paolo Caviglia, et al.
Veröffentlicht: (2025)

Exploration of Hepatitis B Virus Infection Dynamics through Physics-Informed Deep Learning Approach
von: Das, Bikram, et al.
Veröffentlicht: (2025)

Epidemiology of Hepatitis B Virus Infection in Nigeria: A Narrative Review of Prevalence, Transmission, Genotypes, Coinfections, and Mortality
von: Babayemi O. Olakunde, et al.
Veröffentlicht: (2025)

Factors Associated With Underutilization of Antiviral Therapy in Preventing Hepatitis B Virus‐Related Hepatocellular Carcinoma
von: Jia‐Ling Wu, et al.
Veröffentlicht: (2025)

Sustainable Crop Production in Water‐Scarce Regions: Water Footprint and Economic Water Productivity in Indian Punjab
von: Arshdeep Singh, et al.
Veröffentlicht: (2026)

Long‐Acting Amphotericin‐B BSA Nanoparticles for Systemic Fungal Infection
von: Jitu Halder, et al.
Veröffentlicht: (2025)

Encryption‐Based Twining of Visible and Invisible Watermarking for Secure Transmission of Medical Images
von: Rajat Sood, et al.
Veröffentlicht: (2025)

A Framework for Predicting Runtime Savings from Discrete-Event Simulation Model Simplification Operations
von: Shoaib, Mohd, et al.
Veröffentlicht: (2025)

Optimal Control and Cost‐Effectiveness of Vaccination and Treatment for Cholera‐Hepatitis E Co‐Infection
von: Paul Chataa, et al.
Veröffentlicht: (2026)

Less Restrictive Medicaid Policies for Direct‐Acting Antiviral Access Are Associated With Greater Declines in Hepatocellular Carcinoma Deaths
von: Gabriel V. Lupu, et al.
Veröffentlicht: (2026)

Correction to ‘Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon’
Veröffentlicht: (2025)